Abeliovich Asa
Insider CIK 1778476 · PRVL President & CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 250,000 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 1,329,219 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 178,681 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | U Tender | 2021-01-22 | 2021-01-26 | 2,385,756 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | M Exercise deriv | 2020-12-30 | 2020-12-31 | 120,537 | — | $0 | 178,681 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | M Exercise deriv | 2020-12-30 | 2020-12-31 | 5,256 | — | $0 | 1,329,219 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | M Exercise | 2020-12-30 | 2020-12-31 | 5,256 | $0.18 | $946 | 2,354,256 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | M Exercise | 2020-12-30 | 2020-12-31 | 120,537 | $10.26 | $1.24M | 2,474,793 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | F Tax w/h | 2020-12-30 | 2020-12-31 | 89,037 | $23.02 | $2.05M | 2,385,756 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | A Award deriv | 2020-02-19 | 2020-03-11 | 250,000 | — | $0 | 250,000 | SEC↗ |